Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,151.00    12.00 (1.05%)
Bid:
1,150.50
Ask:
1,151.00
Spread: 0.50 (0.043%)
Market Cap: £9.77b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

29 Aug 2025 10:57

RNS Number : 2505X
Smith & Nephew Plc
29 August 2025
 

SMITH & NEPHEW PLC

 

29 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

1. AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020

 

On 27 August 2025, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted to Ajay Dhankhar under the Smith & Nephew Global Share Plan 2020. The awards have been made in London and are based on the closing Share price on the London Stock Exchange between 6 and 19 August 2025 inclusive, of £13.48.

 

i. PERFORMANCE SHARE PROGRAMME 2025 AWARDS

 

The following Performance Share awards will vest as follows:

 

a. *40,005 shares will vest on 8 March 2027 subject to the achievement of performance conditions measured over the period 1 January 2024 to 31 December 2027; and

b. **87,370 shares will vest on 27 August 2028 subject to the achievement of performance conditions measured over the period 1 January 2025 to 31 December 2028.

 

\* The number of shares subject to the above awards are shown at target vesting. Should maximum vesting be achieved, the participant will receive 2x the number of shares shown above. The participant will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

** The number of shares subject to the above awards are shown at maximum vesting. This award will vest proportionally depending upon the extent to which the associated performance conditions are met. The participant will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

The following relates to the individual included in this section:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Performance Share awards granted at target under the

Smith & Nephew Global Share Plan 2020.

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

127,375

N/A Single Transaction

 

 

ii. SHARE AWARDS

 

One third of the share awards detailed below will vest on 27 August 2026, a further third will vest on 27 August 2027, and the final third will vest on 27 August 2028. Each vesting is subject to Ajay Dhankhar remaining in the employment of the Group on the vesting dates, not being under notice and not having achieved an "unsatisfactory performance" rating for his personal performance in the year prior to each vesting date.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Share awards granted under the Smith & Nephew Global Share Plan 2020.

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

82,572

N/A Single Transaction

 

 

 

2. AWARDS MADE UNDER THE RESTRICTED SHARE PLAN 2024

 

On 27 August 2025, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted to Ajay Dhankhar under the Smith & Nephew Restricted Share Plan 2024. The awards have been made in London and are based on the closing Share price on the London Stock Exchange between 6 and 19 August 2025 inclusive, of £13.48.

 

One third of the Restricted Share awards detailed below will vest on 27 August 2026, a further third will vest on 27 August 2027, and the final third will vest on 27 August 2028. Each vesting is subject to Ajay Dhankhar remaining in the employment of the Group on the vesting dates, not being under notice and not having achieved an "unsatisfactory performance" rating for his personal performance in the year prior to each vesting date.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Restricted Share awards granted under the Smith & Nephew Restricted Share Plan 2024

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

39,359

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFEATVIAFIE
Date   Source Headline
9th Feb 201812:20 pmRNSDirector/PDMR Shareholding
8th Feb 20184:49 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSFinal Results
7th Feb 20189:33 amRNSSmith & Nephew announces European launch of PICO 7
2nd Feb 201810:31 amRNSBlock listing Interim Review
1st Feb 20181:40 pmRNSTotal Voting Rights
31st Jan 20189:06 amRNSAppointment of Roland Diggelmann as Non-Exec. Dir.
23rd Jan 201812:00 pmRNSSmith & Nephew update on tax
9th Jan 20184:34 pmRNSDirector/PDMR Shareholding
4th Jan 20184:03 pmRNSDirector Declaration
2nd Jan 20182:33 pmRNSTotal Voting Rights
6th Dec 20172:19 pmRNSSmith & Nephew pilot digital wound care solution
6th Dec 20177:00 amRNSAcquisition of Rotation Medical Inc
1st Dec 20173:09 pmRNSTotal Voting Rights
22nd Nov 201710:25 amRNSDirector/PDMR Shareholding
15th Nov 20173:29 pmRNSTransaction in Own Shares
15th Nov 20178:00 amRNSNew RCT demonstrates effectiveness of ALLEVYN LIFE
13th Nov 20175:00 pmRNSDirector/PDMR Shareholding
13th Nov 20171:00 pmRNSLaunch of robotics-assisted knee replacement
13th Nov 20179:55 amRNSDirector/PDMR Shareholding
8th Nov 20176:03 pmRNSTransaction in Own Shares
8th Nov 201710:31 amRNSDirector/PDMR Shareholding
7th Nov 20175:47 pmRNSTransaction in Own Shares
6th Nov 20172:10 pmRNSTransaction in Own Shares
3rd Nov 20177:00 amRNSTrading Statement
2nd Nov 201712:13 pmRNSDirector/PDMR Shareholding
1st Nov 20171:55 pmRNSTotal Voting Rights
1st Nov 20171:43 pmRNSDirector/PDMR Shareholding
23rd Oct 20172:00 pmRNSAcquisition of tissue regeneration technology
19th Oct 201710:10 amRNSDividend Declaration
13th Oct 20179:00 amRNSNotice of Results
10th Oct 20174:21 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSRetirement of Chief Executive Officer by end 2018
4th Oct 20178:00 amRNSWound Expert Panel Report
2nd Oct 201710:24 amRNSTotal Voting Rights
2nd Oct 20179:00 amRNSDirectorate Change
18th Sep 20179:42 amRNSDirectorate Change
12th Sep 20174:45 pmRNSDirector/PDMR Shareholding
12th Sep 20172:18 pmRNSAdditional Listing
12th Sep 201711:30 amRNSDirectorate Change
5th Sep 20178:00 amRNSSmith & Nephew and Imperial College Partnership
1st Sep 201712:42 pmRNSTotal Voting Rights
16th Aug 20174:54 pmRNSDirector/PDMR Shareholding
15th Aug 20174:38 pmRNSDirector/PDMR Shareholding
14th Aug 20174:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20175:22 pmRNSTransaction in Own Shares
1st Aug 20172:02 pmRNSBlock listing Interim Review
1st Aug 20171:54 pmRNSBlock Listing Cancellation
1st Aug 20171:26 pmRNSTotal Voting Rights
1st Aug 20179:54 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.